On the Regioselectivity of the Nickel-Catalyzed Insertion of Alkynes into the Carbon-Carbon Bond of Oxetan-3-one by Barday, Manuel et al.
On the Regioselectivity of the Nickel-Catalyzed Insertion of Alkynes into the 
Carbon–Carbon Bond of Oxetan-3-one 
Manuel Barday, Christopher Janot, Daniel Clare, Caitlin Carr-Knox, Bradley Higginson, Kelvin Y. T. Ho, 
and Christophe Aïssa* 
Department of Chemistry, University of Liverpool, Crown Street, Liverpool L69 7ZD, UK 
aissa@liverpool.ac.uk 
Received: 31.03.2017 Accepted after revision: 17.05.2017 Published online: 27.06.2017 
DOI: 10.1055/s-0036-1589052; Art ID: ss-2017-c0213-st 
Abstract: The study of the regioselectivity of insertion of unsymmetrical alkynes into the carbon–
carbon bond of oxetan-3-one in the presence of a nickel catalyst has revealed a strong directing 
effect of a 2- thienyl substituent. This effect is larger than those of 2-vinylbenzene, trimethylsilyl, 
aryl, or 3-thienyl groups. 
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Pyrans are prominent heterocycles found in numerous compounds of biological interest1 that display 
various properties such as antibacterial,2 immunosuppressant,3 nematocidal,4 or other inhibitory 
activity5 (Figure 1). Recently, we reported the synthesis of 2H-pyran-3(6H)-ones by insertion of 
alkynes into the carbon–carbon bond of oxetan-3-one in the presence of a nickel catalyst.6–8 This 
reaction is a relatively rare example of metal-catalyzed cleavage of a C–C bond9 in oxetane 
derivatives,10 as C–O bond cleavage is much more frequent under a wide array of conditions.11,12 
Significantly, oxetan-3-one is now an essential building block in the synthesis of numerous oxetane 
derivatives that have recently gained a great interest in medicinal chemistry and pharmaceutical 
industry,13 and it is therefore important to understand its reactivity. Herein, we report on the 
regioselectivity of the insertion of unsymmetrical alkynes into the C–C bond of oxetan-3-one in the 
presence of a nickel catalyst generated in situ from an air-stable Ni(II) precursor. 
In our initial study, we reported only three examples of the nickel-catalyzed cycloaddition of alkynes 
with oxetan- 3-one using a combination of Ni(cod)2 (cod = cyclooctadiene) and triphenylphosphine 
as pre-catalyst.6 Recently, Louie et al. reported that NiCl2(PPh3)2 or NiBr2(PPh3)2 with zinc powder in 
MeCN were also competent systems, but the regioselectivity of the insertion of unsymmetrical 
alkynes into the C–C bond of oxetan-3-one was not examined.14 Moreover, we observed that using 
NiBr2(PPh3)2 and Zn led to inferior results in the regioselective cycloaddition of azetidin-3-ones and 
1,3-enynes when compared to the combination of Ni(cod)2 and PPh3.15 Thus, the cycloaddition of N-
Ts-azetidin-3-one 1 (Ts = p-toluenesulfonyl) with 2- methylhex-1-en-3-yne led to the isolation of 4 in 
only 14% yield (Table 1, entry 1). However, the yield was greatly improved by using THF instead of 
MeCN (entry 2). Moreover, the cycloaddition of N-Boc-azetidin-3-one 2 (Boc = tert-butoxycarbonyl) 
with methylphenylacetylene led to a superior yield of 5 in i-PrOH as compared to the reaction in THF 
(entries 3 vs 4). Focusing our attention on oxetan-3-one 3 and its cycloaddition with bis-
phenylacetylene into 6 (entries 5–9), we found that using NiBr2(PPh3)2 and zinc powder in THF gave 
the best yield (entry 7) when compared to other combinations of pre-catalyst and solvent, and those 
conditions were therefore used in the study of the regioselectivity of the reaction with 
unsymmetrical alkynes 7a–o16 (Scheme 1, method A). It is noteworthy that the zinc powder was used 
without activation.17 
All the cycloadditions of alkynes substituted with a silyl group at one terminus and an aryl or thienyl 
group at the other gave only one regioisomer, as determined by NMR spectroscopy. Thus, 2H-pyran-
3(6H)-ones 8a–d were isolated in 55–85% yield according to our optimized method A (Scheme 1). 
Alkyne 7e with a trimethylsilyl substituent at one terminus and a linear alkyl chain at the other gave 
a mixture 8e and 9e. It is noteworthy that silylated alkynes do not undergo the same reaction with 
cyclobutanones,18 although the strain energies of oxetane, azetidine, and cyclobutane are very 
similar.19 Alkynes substituted with an alkyl group at one terminus and an aryl group at the other gave 
superior yields in the case of an electron-poor aryl group (8g vs 8f and 8h). However, the 
regioselectivity was minimally better in the case of an electron-rich aryl group. Substitution of the 
alkyl chain, even in the homopropargylic position, led to a slight erosion of the regioselectivity (8i). 
Although the origin of this effect is not clear, it is noteworthy that the conditions had to be modified 
by adding 10 mol% of PPh3 and by adding a solution of oxetan-3-one 3 and alkyne 7i to a solution of 
the nickel catalyst in order to obtain 8i in good yield (Scheme 1, method B). The same mode of 
addition was also necessary for this alkyne in our previous protocol based on Ni(cod)2.6 As was the 
case with azetidin-3-ones,15 the reaction of a 1,3-enyne with oxetan- 3-one gave 8j with good 
regioselectivity. Strikingly, a much better regioselectivity was observed when the alkyne was 
substituted with a 2-thienyl group than with the 3-thienyl isomer (8k vs 8l) whereas and the 
regioselectivity was the same when the 2-thienyl group was replaced with a 2-furyl group, although 
8m was only isolated in low to moderate yields. However, 2-pyridylalkynes 8n and 8o did not 
undergo the desired reaction, the former being recovered intact whereas the latter underwent 
decomposition. 
Moreover, it is noteworthy that using a combination of NiCl2(PPh3)2 and Zn in MeCN (Scheme 1, 
method C) led to a markedly decreased yield in the case of 8m, when compared with the other 
methods, whereas regioselectivity in the of case 8g was slightly inferior when we used this method. 
On the other hand, the previously reported method relying on Ni(cod)2 and PPh3 in 1,4-dioxane 
(Scheme 1, method D)6 and the method relying on NiBr2(PPh3)2 and Zn in THF (Scheme 1, method A) 
gave very good results both with challenging substrates (e.g., 7c into 8c) and with more reactive 
substrates (e.g., 7g into 8g). 
The markedly enhanced regioselectivity observed in the conversion of 2-(hex-1-yn-1-yl)thiophene 
(7k) into 8k when compared to the conversion of 3-(hex-1-yn-1-yl)thiophene (7l) into 8l could be 
explained by η1 -coordination of the sulfur atom (Scheme 2),20 either in oxidative cyclization 
transition state I towards intermediate II (pathway a) or in transition state IV from intermediates III 
to V (pathway b). Both pathways would converge towards intermediate V that would then liberate 
the catalyst and the major regioisomer of 8k. 
Pathway a would be in agreement with recent theoretical studies of the nickel-catalyzed reductive 
coupling of alkynes and aldehydes,21 whereby the η1-coordination of the sulfur atom in I and II 
would replace the η3-coordination proposed to explain the regioselectivity observed for 1,3-
enynes.22 It would also be in agreement with several isolated nickel-dihydrofuran complexes.23 
However, recent theoretical studies by Lin and Li suggest that the rearrangement of II into V is not 
kinetically viable under the reaction conditions, and the direct C–C oxidative addition of 3 to the 
active nickel catalyst would instead be much more feasible and lead to III.24 Nevertheless, the 
regioselectivity of the insertion of alkyne 7k into the C(sp2)–Ni bond of III to V via transition state IV25 
would also be controlled by the η1-coordination of the sulfur atom of the thienyl group. Accordingly, 
the difference of regioselectivity observed during the formation of 8k and 8l would not be easily 
explained by invoking a η2-coordination of the thienyl group in either of the pathways, as both 2-
thienyl and 3-thienyl isomers would be equally capable of such coordination in both pathways. 
Similarly, neither η1-coordination nor η2-coordination of the thienyl group are possible if we 
postulate an insertion of alkyne 7k into the C(sp3)–Ni bond of III in the pathway leading to the major 
regioisomer of 8k. It would follow that only the cleavage of C(sp2)–Ni bond in III occurs in pathway b, 
as we would otherwise obtain the same level of regioselectivity for 8k and 8l. 
Moreover, as discussed previously,6 and on the basis of the NMR data of isolated nickel-alkyne 
complexes,26 the electronic density at the alkyne terminus attached to the silyl group is greater than 
at the other terminus, and insertion of the alkyne into the polarized C(sp3)(δ–)–Ni(δ+) bond of the 
metallacycle that results from the oxidative addition of the catalyst into the C–C bond of oxetan-3-
one 3 would then match the polarization of the alkyne in the reactions leading to 8a–e.24,26 This 
electronic effect can overcome steric hindrance, as illustrated with the formation of 8e as major 
regioisomer. Overall, by comparing the ratios of regioisomers for 8e–h and 8j–m, the influence of 
substituents on the regioselectivity of the alkyne insertion in this reaction decreases in the order 2-
thienyl, 2-furyl > 2-vinylbenzene > trimethylsilyl > aryl ~ 3-thienyl. 
We also examined the regioselectivity of the ring opening with substituted oxetan-3-one 10 that was 
prepared by the method reported by Zhang.27 In stark contrast to the nickel-catalyzed insertion of 
alkynes in substituted azetidin-3-ones that leads exclusively to the cleavage of the least sterically 
hindered C–C bond,6,7b,14,15 we observed that the reaction of 10 with oct-4-yne led to a mixture of 
regioisomers 11 and 12, independently of the pre-catalyst, although combining Ni(cod)2 and PPh3 in 
1,4-dioxane gave a much superior yield and better regioselectivity (Scheme 3). This result also 
contrasts with the closely related nickel-catalyzed cycloadditions of 1,6-diynes with 
cyclobutanones,28 of alkynes and 1,3-dienes with benzocyclobutanones,29 and of 1,3-dienes with 
azetidin-3-ones.10b In all cases, only cleavage of the least sterically hindered C–C bond of the 4- 
membered ring was observed. The decrease of regioselectivity in the ring cleavage of 10, as 
compared to the selectivity observed for similarly substituted azetidin-3-ones with various 
protective groups on the nitrogen atom,6,7b,14,15 is likely a result of the decreased steric bulk around 
the oxygen atom of the oxetane. 
In conclusion, we have examined the regioselectivity of the insertion of unsymmetrical alkynes in 
oxetan-3-one in the presence of a nickel catalyst generated in situ from an air-stable precursor and 
we have observed that the 2-thienyl group exerts a stronger directing effect than 2-vinylbenzene or 
trimethylsilyl substituents and approximately twice as strong as the 3-thienyl group or other aryl 
groups. 
 
Figure 1 Examples of biologically active compounds containing a pyran motif. 
Table 1 Optimisation of general reaction conditionsa 
 
entry product Ni(II) catalystb solvent t (°C) yield (%)c r.r.d 
1 4 NiBr2(PPh3)2 MeCN 70 14 84:16 
2 4 NiBr2(PPh3)2 THF 70 67 83:17 
3 5 NiBr2(PPh3)2 iPrOH 40 84 89:11 
4 5 NiBr2(PPh3)2 THF 40 60 90:10 
5 6 NiBr2(PPh3)2 iPrOH 70 50 n.a. 
6 6 NiBr2(PPh3)2 MeCN 70 76 n.a. 
7 6 NiBr2(PPh3)2 THF 70 86 n.a. 
8 6 NiCl2(PPh3)2 MeCN 80 77 n.a. 
9 6 NiCl2(PPh3)2 THF 70 13 n.a. 
a Reaction conditions: 1–3 (0.22 mmol), alkyne (0.24 mmol), Ni(II) catalyst (0.022 mmol), Zn powder (0.11 mmol), solvent (0.2 M), 17 h except otherwise 
noted. b 5 mol% of Ni(II) catalyst was used in entries 3 and 4. C Yield of combined regioisomers after isolation. d Regioisomers ratio determined by 1H 
NMR of the crude mixture. 
 
Scheme 1 Regioselective insertion of unsymmetrical alkynes into the C–C bond of oxetan-3-one. Reaction conditions: [A] as in table 1, entry 7; [B] as 
[A] but 10 mol% PPh3 was added whilst oxetan-3-one and the alkyne were added as a THF solution to a solution of the nickel catalyst; [C] as in table 1, 
entry 8; [D] 10 mol% Ni(cod)2, 30 mol% PPh3, dioxane, 90 °C.6 Yields are given for the combined regioisomers after isolation. The ratio of regioisomers 
(8/9) is given in parentheses and was determined from purified material except for 8g (ratio from crude material). 
 
Scheme 2 Possible rationale explaining the enhanced regioselectivity of the insertion of 2-(hex-1-yn-1-yl)thiophene 7k during the formation of 8k.  
 
Scheme 3 Regioselective C–C cleavage of substituted oxetan-3-one 10. Reaction conditions: [A] as in table 1, entry 7; [D] 10 mol% Ni(cod)2, 30 mol% 
PPh3, dioxane, 90 °C. 
  
Unless otherwise noted, all reactions were carried out in flame-dried glassware under dry N2 
atmosphere. THF was purified with the solvent purification system Pure Solv MD-6 from innovative 
Technology. MeCN and 1,4-dioxane were purchased as anhydrous solvent on MS 4Å. Merck silica gel 
60 (230–00 mesh) was used for chromatography. NMR: Spectra were recorded on a Bruker DRX 500 
in CDCl3; chemical shifts (δ) are given in ppm. The solvent signals were used as references and the 
chemical shifts converted to the TMS scale (CDCl3: δC = 77.0; residual CHCl3 in CDCl3: δH = 7.26); 
apparent splitting patterns are designated using the standard abbreviations. In 13C NMR, an APT 
sequence was used to separate methylene groups and quaternary carbons (e, even) from methine 
and methyl groups (o, odd). The regiochemistry of 8a–m, 11, and 12 was established by either HMBC 
or NOE experiments. IR: PerkinElmer Spectrum 100 FT-IR spectrophotometer. The intensity of the 
peaks is indicated by w (weak), m (medium), and s (strong). High-resolution mass spectra (HRMS) 
were determined at the University of Liverpool on micromass LCT mass spectrometer (ESI) and Trio-
1000 or Agilent QTOF 7200 mass spectrometers (CI). Melting points: Griffin melting point apparatus 
(not corrected). Elemental analyses: University of Liverpool. Compounds 1, 6 2, 6 4–6, 6 7a, 30 7b, 31 
7e, 32 7f, 33 7g, 6 7h, 34 7i, 6 7j, 15 7k, 19 7l, 19 7m, 35 7n, 36 8c, 6 8g, 6 and 1027 were described 
previously. Compounds 3, 7c, and 7d are commercially available. All commercially available reagents 
were used as received. 
2-(Hex-1-yn-1-yl)-4,6-dimethylpyrimidine (7o) CuI (12 mg, 0.06 mmol, 0.02 equiv), PdCl2(PPh3)2 (42 
mg, 0.06 mmol, 0.02 equiv), PPh3 (30 mg, 0.12 mmol, 0.04 equiv), anhyd i-Pr2NEt (12 mL), anhyd 
Et3N (3 mL), 2-chloro-4,6-dimethylpyrimidine (426 mg, 3 mmol, 1 equiv), and hex-1-yne (0.52 mL, 
4.5 mmol, 1.5 equiv) were added under N2 to a flame-dried two neck round bottom flask. The 
mixture was stirred at 100 °C for 68 h. The crystalline precipitate was filtered off and all volatiles 
were removed under vacuum. Purification of the oily residue by flash chromatography (PE/EtOAc, 
85:15) gave 7o as a yellow oil; yield: 171 mg (30%); Rf = 0.3. FT-IR (neat): 2959 (w), 2933 (w), 2242 
(m), 1583 (s), 1536 (m), 1459 (w), 1440 (m), 1369 (s), 1343 (w), 957 (s), 908 (w), 856 (m), 725 cm–1 
(vs). 1H NMR (CDCl3, 500 MHz): δ = 6.89 (s, 1 H), 2.48–2.37 (m, 8 H), 1.59 (quint, J = 7.3 Hz, 2 H), 1.43 
(sext, J = 7.4 Hz, 2 H), 0.88 (t, J = 7.5 Hz, 3 H). 13C NMR (CDCl3, 125 MHz): δ = 166.9 (e, 2 C), 152.5 
(e), 118.6 (o), 89.5 (e), 79.9 (e), 30.0 (e), 23.8 (o, 2 C), 22.0 (e), 18.9 (e), 13.5 (o). MS (CI): m/z (%) = 
189 (10) [M + H]+. HRMS (CI): m/z [M + H]+ calcd for C12H17N2: 189.1386; found: 189.1393. 
Nickel-Catalyzed Cycloadditions of Alkynes with Oxetan-3-one 
General Procedures 
Method A: A J-Young Teflon-screw flame-dried Schlenk tube equipped with a small stirrer bar was 
charged with NiBr2(PPh3)2 (16 mg, 0.022 mmol, 0.1 equiv), Zn (7 mg, 0.111 mmol, 0.5 equiv), and 
degassed THF (0.4 mL) under N2. Then, 3 (14 μL, 0.22 mmol, 1.0 equiv) and the alkyne (0.244 mmol, 
1.1 equiv) were added, followed by THF (0.6 mL). The tube was sealed and the mixture was stirred at 
70 °C (oil bath temperature) for 17 h before being filtered through a small plug of silica gel. After 
evaporation of all volatiles under reduced pressure, the relevant 2H-pyran-3(6H)-one was obtained 
after purification by flash chromatography as specified. 
Method B: This method was identical to method A except that the alkyne (0.244 mmol, 1.1 equiv) 
was dissolved in THF (0.6 mL) and that this solution was added to a mixture made of NiBr2(PPh3)2, 
Zn, and PPh3 (5.8 mg, 0.022 mmol, 0.1 equiv) in THF (0.4 mL), before sealing the Schlenk tube. 
Method C: This method was identical to method A except that the reaction temperature of the oil 
bath was set at 80 °C and that NiCl2(PPh3)2 (14 mg, 0.022 mmol, 0.1 equiv) and MeCN (1 mL) were 
used instead of NiBr2(PPh3)2 and THF, respectively. 
5-[4-(Trifluoromethyl)phenyl]-4-(trimethylsilyl)-2H-pyran- 3(6H)-one (8a). This compound was 
obtained from 7a (59 mg, 0.244 mmol, 1.1 equiv) according to method A. Flash chromatography 
(PE/EtOAc, 9:1) afforded 8a as a white amorphous solid; yield: 59 mg (85%); Rf = 0.3. FT-IR (neat): 
2962 (w), 1662 (s), 1570 (m), 1435 (m), 1407 (w), 1323 (vs), 1242 (s), 1164 (s), 1128 (vs), 1109 (vs), 
1069 (vs), 1028 (m), 1014 (m), 977 (w), 934 (m), 828 (vs), 759 (m), 688 cm–1 (w). 1H NMR (CDCl3, 
500 MHz): δ = 7.68 (d, J = 8.2 Hz, 2 H), 7.37 (d, J = 8.2 Hz, 2 H), 4.41 (s, 2 H), 4.18 (s, 2 H), –0.10 (s, 9 
H). 13C NMR (CDCl3, 125 MHz): δ = 197.7 (e), 166.9 (e), 141.4 (e), 137.4 (e), 131.5 (e, q, J = 33.1 Hz), 
128.3 (o, 2 C), 125.5 (o, q, J = 4.0 Hz, 2 C), 123.7 (e, q, J = 272.6 Hz), 71.5 (e), 70.1 (e), 0.2 (o, 3 C). 
Anal. Calcd for C15H17F3O2Si: C, 57.31; H, 5.45. Found: C, 57.11; H, 5.44. 
4-[Dimethyl(phenyl)silyl]-5-phenyl-2H-pyran-3(6H)-one (8b). This compound was obtained from 7b 
(58 mg, 0.244 mmol, 1.1 equiv) according to method A. Flash chromatography (PE/EtOAc, 9:1) 
afforded 8b as a white amorphous solid; yield: 39 mg (57%); Rf = 0.3. FT-IR (neat): 3050 (w), 2951 
(w), 1656 (vs), 1600 (w), 1560 (s), 1488 (m), 1424 (m), 1376 (m), 1291 (s), 1277 (s), 1254 (s), 1138 (s), 
1114 (s), 1079 (w), 1052 (w), 969 (m), 938 (s), 837 (vs), 809 (vs), 775 (m), 760 (s), 698 cm–1 (vs). 1H 
NMR (CDCl3, 500 MHz): δ = 7.52–7.45 (m, 2 H), 7.36 (tt, J = 6.4, 1.3 Hz, 1 H), 7.32–7.25 (m, 6 H), 
7.15–7.10 (m, 2 H), 4.45 (s, 2 H), 4.18 (s, 2 H), 0.09 (s, 6 H). 13C NMR (CDCl3, 125 MHz): δ = 197.9 (e), 
170.2 (e), 138.7 (e), 137.5 (e), 135.0 (e), 133.9 (o, 2 C), 129.6 (o), 128.7 (o), 128.4 (o, 2 C), 128.0 (o, 2 
C), 127.5 (o, 2 C), 71.5 (e), 70.3 (e), –1.2 (o, 2 C). MS (ESI): m/z (%) = 331 (100) [M + Na]+. HRMS (ESI): 
m/z [M + Na]+ calcd for C19H20O2SiNa: 331.1130; found: 331.1125. 
5-Phenyl-4-(trimethylsilyl)-2H-pyran-3(6H)-one (8c). This compound was obtained from 7c (43 mg, 
0.244 mmol, 1.1 equiv) according to method A. Flash chromatography (PE/EtOAc, 9:1) afforded 8c as 
a colorless oil; yield: 40 mg (73%); Rf = 0.3. The analytical data obtained were in agreement with that 
previously published.6  
5-(Thiophen-3-yl)-4-(trimethylsilyl)-2H-pyran-3(6H)-one (8d). This compound was obtained from 7d 
(44 mg, 0.244 mmol, 1.1 equiv) according to method A. Flash chromatography (PE/EtOAc, 95:5) 
afforded 8d as a pale pink amorphous solid; yield: 31 mg (55%); Rf = 0.25. FT-IR (neat): 3106 (w), 
2964 (w), 2898 (w), 2866 (w), 2820 (w), 1753 (m), 1654 (vs), 1567 (s), 1431 (m), 1420 (w), 1409 (w), 
1359 (w), 1273 (s), 1240 (s), 1182 (m), 1130 (s), 1065 (w), 1051 (w), 1032 (w), 966 (m), 940 (m), 926 
(m), 834 (vs), 784 (s), 697 cm–1 (m). 1H NMR (CDCl3, 500 MHz): δ = 7.39 (dd, J = 3.0, 2.1 Hz, 1 H), 
7.27 (d, J = 1.3 Hz, 1 H), 7.05 (dd, J = 3.6, 1.3 Hz, 1 H), 4.42 (s, 2 H), 4.14 (s, 2 H), – 0.02 (s, 9 H). 13C 
NMR (CDCl3, 125 MHz): δ = 198.3 (e), 163.6 (e), 138.4 (e), 136.7 (e), 127.5 (o), 126.6 (o), 125.5 (o), 
71.6 (e), 70.0 (e), 0.1 (o, 3 C). MS (CI): m/z (%) = 253 (8) [M + H]+. HRMS (CI): m/z [M + H]+ calcd for 
C12H17O2SSi: 253.0640; found: 253.0722. Anal. Calcd for C12H16O2SSi: C, 57.10; H, 6.39; S, 12.70. 
Found: C, 56.39; H, 6.29; S, 12.59. 
5-(3-Phenylpropyl)-4-(trimethylsilyl)-2H-pyran-3(6H)-one (8e). This compound was obtained from 
7e (106 mg, 0.448 mmol, 1.1 equiv) according to method A. Flash chromatography (PE/EtOAc, 95:5) 
afforded the major regioisomer 8e [pale yellow oil; yield: 84 mg (66%); Rf = 0.25] besides the minor 
regioisomer 9e [pale yellow oil; yield: 13 mg (10%); Rf = 0.3]. 
Major Regioisomer 8e FT-IR (neat): 3062 (w), 3026 (w), 2945 (w), 2857 (w), 2812 (w), 1663 (s), 1583 
(m), 1496 (w), 1453 (w), 1436 (w), 1378 (w), 1279 (m), 1246 (m), 1187 (w), 1139 (w), 1115 (m), 1082 
(w), 1055 (w), 1029 (w), 964 (w), 936 (w), 841 (s), 765 (m), 750 (m), 699 (m), 641 (w), 624 cm–1 (w). 
1H NMR (CDCl3, 500 MHz): δ = 7.35–7.29 (m, 2 H), 7.23–7.19 (m, 1 H), 7.18–7.15 (m, 2 H), 4.18 (s, 2 
H), 4.01 (s, 2 H), 2.70–2.62 (m, 2 H), 2.35–2.28 (m, 2 H), 1.85–1.75 (m, 2 H), 0.2 (s, 9 H). 13C NMR 
(CDCl3, 125 MHz): δ = 197.9 (e), 171.0 (e), 141.0 (e), 134.4 (e), 128.6 (o, 2 C), 128.4 (o, 2 C), 126.2 
(o), 71.5 (e), 68.6 (e), 36.0 (e), 33.7 (e), 31.0 (e), 1.1 (o, 3 C). MS (ESI): m/z (%) = 311 (100) [M + Na]+. 
HRMS (ESI): m/z [M + Na]+ calcd for C17H24O2SiNa: 311.1443; found: 311.1437. Anal. Calcd for 
C17H24O2Si: C, 70.78; H, 8.39. Found: C, 70.59; H, 8.49. 
Minor Regioisomer 9e 1H NMR (CDCl3, 500 MHz): δ = 7.30–7.25 (m, 2 H), 7.20–7.15 (m, 3 H), 4.35 (s, 
2 H), 4.10 (s, 2 H), 2.66 (t, J = 7.7 Hz, 2 H), 2.40–2.33 (m, 2 H), 1.75–1.70 (m, 2 H), 0.15 (s, 9 H). 13C 
NMR (CDCl3, 125 MHz): δ = 193.6 (e), 156.7 (e), 144.6 (e), 142.0 (e), 128.5 (o, 2 C), 128.3 (o, 2C), 
125.8 (o), 72.1 (e), 68.8 (e), 36.2 (e), 31.6 (e), 29.1 (e), –0.84 (o, 3 C). 
4-Octyl-5-phenyl-2H-pyran-3(6H)-one (8f). This compound was obtained from 7f (52 mg, 0.244 
mmol, 1.1 equiv) according to method A. Flash chromatography (PE/EtOAc, 9:1) afforded the major 
regioisomer 8f [yellow oil; yield: 28 mg (45%); Rf = 0.3] besides the minor regioisomer 9f [yellow oil; 
yield: 9 mg (14%); Rf = 0.25]. 
Major Regioisomer 8f: FT-IR (neat): 2955 (m), 2924 (s), 2854 (m), 2815 (w), 1680 (vs), 1625 (w), 1491 
(w), 1442 (m), 1379 (m), 1335 (m), 1245 (m), 1146 (s), 1119 (s), 1074 (w), 964 (m), 758 (s), 700 cm–1 
(vs). 1H NMR (CDCl3, 500 MHz): δ = 7.46–7.36 (m, 3 H), 7.24–7.20 (m, 2 H), 4.52 (s, 2 H), 4.23 (s, 2 H), 
2.24–2.18 (m, 2 H), 1.37–1.09 (m, 12 H), 0.85 (t, J = 7.1 Hz, 3 H). 13C NMR (CDCl3, 125 MHz): δ = 
194.8 (e), 154.7 (e), 135.9 (e), 134.6 (e), 128.73 (o), 128.67 (o, 2 C), 127.3 (o, 2 C), 72.0 (e), 69.7 (e), 
31.8 (e), 29.5 (e), 29.13 (e), 29.10 (e, 2 C), 25.1 (e) 22.6 (e), 14.1 (o). MS (CI): m/z (%) = 287 (100) [M 
+ H]+. HRMS (CI): m/z [M + H]+ calcd for C19H27O2: 287.2006; found: 287.2016. 
Minor Regioisomer 9f: 1H NMR (CDCl3, 500 MHz): δ = 7.42–7.36 (m, 2 H), 7.36–7.31 (m, 1 H), 7.14–
7.07 (m, 2 H), 4.48 (s, 2 H), 4.26 (s, 2 H), 2.17–2.09 (m, 2 H), 1.44–1.35 (m, 2 H), 1.30–1.09 (m, 10 H), 
0.86 (t, J = 7.0 Hz, 3 H). 13C NMR (CDCl3, 125 MHz): δ = 193.2 (e), 159.0 (e), 135.3 (e), 133.0 (e), 
129.8 (o, 2 C), 128.2 (o, 2 C), 127.7 (o), 72.2 (o), 68.2 (o), 31.73 (e), 31.65 (e), 29.5 (e), 29.03 (e), 
28.97 (e), 27.9 (e), 22.6 (e), 14.1 (o). 
5-(4-Acetylphenyl)-4-butyl-2H-pyran-3(6H)-one (8g). This compound was obtained from 7g (98 mg, 
0.488 mmol, 1.1 equiv) according to method A. Flash chromatography (PE/EtOAc, 9:1) afforded the 
major regioisomer 8g [colorless oil; yield: 79 mg (65%); Rf = 0.3] as well as a mixture of 8g and 9g 
(1:3.9) [colorless oil; yield: 41 mg (31%)]. The analytical data obtained were in agreement with that 
previously published.6 
4-Butyl-5-(4-methoxyphenyl)-2H-pyran-3(6H)-one (8h). This compound was obtained from 7h (46 
mg, 0.244 mmol, 1.1 equiv) according to method A. Flash chromatography (PE/EtOAc, 9:1) afforded 
the major regioisomer 8h [yellow oil; yield: 31 mg (54%); Rf = 0.3] besides 9h [yellow oil; yield: 7 mg 
(12%); Rf = 0.2]. 
Major Regioisomer 8h: FT-IR (neat): 2957 (m), 2930 (m), 2859 (m), 1675 (vs), 1606 (s), 1573 (w), 
1510 (s), 1462 (m), 1441 (m), 1379 (m), 1336 (m), 1289 (s), 1250 (vs), 1177 (s), 1150 (vs), 1116 (s), 
1075 (w), 1039 (m), 1026 (s), 966 (m), 921 (m), 831 (s), 723 cm–1 (m). 1H NMR (CDCl3, 500 MHz): δ = 
7.20–7.15 (m, 2 H), 6.97–6.93 (m, 2 H), 4.50 (s, 2 H), 4.21 (s, 2 H), 3.84 (s, 3 H), 2.26 (dd, J = 9.2, 7.3 
Hz, 2 H), 1.36–1.29 (m, 2 H), 1.23–1.16 (m, 2 H), 0.78 (t, J = 7.3 Hz, 3 H). 13C NMR (CDCl3, 125 MHz): 
δ = 194.9 (e), 160.0 (e), 154.5 (e), 134.3 (e), 129.0 (o, 2 C), 128.1 (e), 114.1 (o, 2 C), 72.0 (e), 69.8 (e), 
55.3 (o), 31.4 (e), 25.0 (e), 22.6 (e), 13.8 (o). MS (CI): m/z (%) = 261 (100) [M + H]+. HRMS (CI): m/z 
[M + H]+ calcd for C16H21O3: 261.1485; found: 261.1489. 
Minor Regioisomer 9h: 1H NMR (CDCl3, 500 MHz): δ = 7.03 (d, J = 8.7 Hz, 2 H), 6.92 (d, J = 8.6 Hz, 2 
H), 4.46 (s, 2 H), 4.25 (s, 2 H), 3.82 (s, 3 H), 2.18–2.13 (m, 2 H), 1.43–1.35 (m, 2 H), 1.27–1.19 (m, 2 
H), 0.81 (t, J = 7.3 Hz, 3 H). 13C NMR (CDCl3, 125 MHz): δ = 193.5 (e), 159.1 (e), 158.9 (e), 134.8 (e), 
130.9 (o, 2 C), 125.1 (e), 113.7 (o, 2 C), 72.2 (e), 68.3 (e), 55.2 (o), 31.5 (e), 30.1 (e), 22.7 (e), 13.7 (o). 
4-Isobutyl-5-(4-methoxyphenyl)-2H-pyran-3(6H)-one (8i): This compound was obtained from 7i (46 
mg, 0.244 mmol, 1.1 equiv) according to method B. Flash chromatography (PE/EtOAc, 9:1) afforded 
the major regioisomer 8i [yellow oil; yield: 30 mg (52%); Rf = 0.4] besides 9i [yellow oil; yield: 8 mg 
(14%); Rf = 0.2]. 
Major Regioisomer 8i: FT-IR (neat): 2956 (m), 2868 (w), 1727 (w), 1675 (s), 1605 (s), 1510 (s), 1463 
(m), 1440 (w), 1382 (m), 1326 (m), 1291 (m), 1247 (vs), 1177 (m), 1153 (s), 1116 (m), 1025 (m), 1007 
(m), 968 (m), 896 (w), 833 cm–1 (s). 1H NMR (CDCl3, 500 MHz): δ = 7.16 (d, J = 8.9 Hz, 2 H), 6.94 (d, J 
= 8.8 Hz, 2 H), 4.50 (s, 2 H), 4.22 (s, 2 H), 3.84 (s, 3 H), 2.21 (d, J = 7.2 Hz, 2 H), 1.68 (sept, J = 6.9 Hz, 1 
H), 0.71 (d, J = 6.5 Hz, 6 H). 13C NMR (CDCl3, 125 MHz): δ = 195.1 (e), 159.9 (e), 155.7 (e), 133.5 (e), 
129.3 (o, 2C), 128.1 (e), 114.1 (o, 2C), 72.0 (e), 70.1 (e), 55.3 (o), 33.4 (e), 27.8 (o), 22.4 (o). MS (CI): 
m/z (%) = 261 (100) [M + H]+. HRMS (CI): m/z [M + H]+ calcd for C16H21O3: 261.1485; found: 
261.1494. 
Minor Regioisomer 9i: 1H NMR (CDCl3, 500 MHz): δ = 7.01 (d, J = 8.8 Hz, 2 H), 6.92 (d, J = 8.7 Hz, 2 
H), 4.44 (s, 2 H), 4.26 (s, 2 H), 3.83 (s, 3 H), 2.10 (d, J = 7.6 Hz, 2 H), 1.72 (sept, J = 6.9 Hz, 1 H), 0.82 (d, 
J = 6.6 Hz, 6 H). 13C NMR (CDCl3, 125 MHz): δ = 193.6 (e), 159.0 (e), 157.9 (e), 135.8 (e) 131.1 (o, 2 
C), 125.2 (e), 113.7 (o, 2 C), 72.3 (e), 68.6 (e), 55.2 (o), 40.8 (e), 27.1 (o), 22.6 (o). 
(E)-4-Octyl-5-styryl-2H-pyran-3(6H)-one (8j). This compound was obtained from 7j (59 mg, 0.244 
mmol, 1.1 equiv) according to method A. Flash chromatography (PE/EtOAc, 9:1) afforded 8j as a 
yellow amorphous solid; yield: 98 mg (71%); and a mixture of regioisomers 8j/9j (7.9:1); Rf = 0.3; 
only the major regioisomer is described below. FT-IR (neat): 3061 (w), 2917 (m), 2850 (m), 1665 (s), 
1614 (m), 1585 (w), 1494 (w), 1466 (w), 1444 (w), 1419 (w), 1343 (m), 1325 (m), 1306 (w), 1288 (w), 
1244 (m), 1131 (m), 1121 (m), 956 (s), 723(s), 689 (m), 668 cm–1 (s). 1H NMR (CDCl3, 500 MHz): δ = 
7.52–7.47 (m, 2 H), 7.42–7.37 (m, 3 H), 7.18 (d, J = 16.5 Hz, 1 H), 6.80 (d, J = 16.5 Hz, 1 H), 4.69 (s, 2 
H, major), 4.19 (s, 2 H), 2.57–2.50 (m, 2 H), 1.47–1.22 (m, 12 H), 0.91–0.83 (m, 3 H). 13C NMR 
(CDCl3, 125 MHz): δ = 194.4 (e), 147.4 (e), 136.1 (e), 134.9 (e), 134.8 (o), 129.3 (o), 128.9 (o, 2 C), 
127.2 (o, 2 C), 122.5 (o), 72.0 (e), 65.4 (e), 31.9 (e), 29.8 (e), 29.6 (e), 29.4 (e), 29.2 (e), 23.5 (e), 22.6 
(e), 14.1 (o). MS (CI): m/z (%) = 313 (100) [M + H]+. HRMS (CI): m/z [M + H]+ calcd for C21H29O2: 
313.2162; found: 313.2174. 
4-Butyl-5-(thiophen-2-yl)-2H-pyran-3(6H)-one (8k). This compound was obtained from 7k (80 mg, 
0.488 mmol, 1.1 equiv) according to method A. Flash chromatography (PE/EtOAc, 95:5) afforded the 
major regioisomer 8k [amorphous brown solid; yield: 65 mg (63%); Rf = 0.3] as well as a mixture of 
8k and 9k (1:6.5) [amorphous brown solid; yield: 10 mg (9%)]. 
Major Regioisomer 8k: FT-IR (neat): 3120 (w), 3075 (w), 2958 (w), 2922 (w), 2858 (w), 1661 (s), 1590 
(s), 1511 (w), 1467 (w), 1454 (w), 1435 (m), 1416 (m), 1387 (w), 1337 (m), 1319 (s), 1280 (s), 1227 
(m), 1184 (m), 964 (s), 860 (m), 730 (s), 714 cm–1 (s). 1H NMR (CDCl3, 500 MHz): δ = 7.53 (dd, J = 
5.0, 1.0 Hz, 1 H), 7.22 (dd, J = 3.8, 1.0 Hz, 1 H), 7.14 (dd, J = 5.0, 3.8 Hz, 1 H), 4.68 (s, 2 H), 4.21 (s, 2 
H), 2.59 (m, 2 H), 1.48–1.34 (m, 4 H), 0.91 (t, J = 7.2 Hz, 3 H). 13C NMR (CDCl3, 125 MHz): δ = 194.3 
(e), 145.1 (e), 136.8 (e), 133.9 (e), 128.7 (o), 128.4 (o), 127.7 (o), 71.9 (e), 69.2 (e), 30.9 (e), 25.4 (e), 
22.9 (e), 13.9 (o). MS (CI): m/z (%) = 237 (100) [M + H]+. HRMS (CI): m/z [M + H]+ calcd for 
C13H17O2S: 237.0944; found: 237.0950. Anal. Calcd for C13H16O2S: C, 66.07; H, 6.82; S, 13.57. 
Found: C, 66.90; H, 7.17; S, 13.25. 
Minor Regioisomer 9k: 1H NMR (CDCl3, 500 MHz): δ = 7.40 (dd, J = 5.0, 1.2 Hz, 1 H), 7.07 (dd, J = 
5.00, 3.5 Hz, 1 H), 6.94 (dd, J = 3.5, 1.2 Hz, 1 H), 4.48 (s, 2 H), 4.27 (s, 2 H), 2.35–2.29 (m, 2 H), 1.52–
1.43 (m, 2 H), 1.35–1.22 (m, 2 H), 0.87 (t, J = 7.3 Hz, 3 H). 13C NMR (CDCl3, 125 MHz): δ = 192.5 (e), 
161.3 (e), 132.3 (e), 128.5 (e), 128.3 (o), 126.7 (o), 126.6 (o), 72.2 (e), 68.6 (e), 31.8 (e), 30.4 (e), 22.8 
(e), 13.7 (o). 
4-Butyl-5-(thiophen-3-yl)-2H-pyran-3(6H)-one (8l). This compound was obtained from 7l (40 mg, 
0.244 mmol, 1.1 equiv) according to method A. Flash chromatography (PE/EtOAc, 95:5) afforded the 
major regioisomer 8l [pale yellow oil; yield: 28 mg (53%); Rf = 0.3] besides 9l [colorless oil; yield: 6 
mg (11%); Rf = 0.2]. 
Major Regioisomer 8l: FT-IR (neat): 3102 (w), 2956 (m), 2928 (m), 2858 (w), 2814 (w), 1670 (s), 1612 
(m), 1439 (w), 1409 (w), 1378 (w), 1360 (w), 1329 (m), 1283 (m), 1227 (w), 1191 (w), 1145 (s), 1118 
(m), 945 (w), 900 (m), 869 (w), 839 (m), 783 (s), 720 (m), 701 cm–1 (m). 1H NMR (CDCl3, 500 MHz): δ 
= 7.42 (dd, J = 5.0, 2.9 Hz, 1 H), 7.33 (dd, J = 2.9, 1.4 Hz, 1 H), 7.09 (dd, J = 5.0, 1.4 Hz, 1 H), 4.56 (s, 2 
H), 4.21 (s, 2 H), 2.37 (m, 2 H), 1.42–1.36 (m, 2 H), 1.28 (m, 2 H), 0.84 (t, J = 7.3 Hz, 3 H). 13C NMR 
(CDCl3, 125 MHz): δ = 194.7 (e), 148.7 (e), 136.1 (e), 134.6 (e), 127.1 (o), 126.5 (o), 124.8 (o), 72.0 
(e), 69.3 (e), 31.4 (e), 25.2 (e), 22.8 (e), 13.8 (o). MS (CI): m/z (%) = 237 (100) [M + H]+. HRMS (CI): 
m/z [M + H]+ calcd for C13H17O2S: 237.0944; found: 237.0947. Anal. Calcd for C13H16O2S: C, 
66.07; H, 6.82; S, 13.57. Found: C, 65.59; H, 6.95; S, 12.90. 
Minor Regioisomer 9l: 1H NMR (CDCl3, 500 MHz): δ = 7.35 (dd, J = 5.0, 3.0 Hz, 1 H), 7.15 (dd, J = 3.0, 
1.3 Hz, 1 H), 6.95 (dd, J = 5.0, 1.3 Hz, 1 H), 4.46 (s, 2 H), 4.25 (s, 2 H), 2.24 (m, 2 H), 1.43 (m, 2 H), 1.28 
(m, 2 H), 0.84 (t, J = 7.4 Hz, 3 H). 13C NMR (CDCl3, 125 MHz): δ = 193.0 (e), 159.7 (e), 132.4 (e), 130.3 
(e), 129.0 (o), 124.9 (o), 124.7 (o), 72.2 (e), 68.4 (e), 31.6 (e), 30.3 (e), 22.8 (e), 13.7 (o). 
4-Butyl-5-(furan-2-yl)-2H-pyran-3(6H)-one (8m). This compound was obtained from 7m (36 mg, 
0.244 mmol, 1.1 equiv) according to method A. Flash chromatography (PE/EtOAc, 95:5) afforded 8m 
as a brown oil; yield: 14 mg (28% yield); and a mixture of regioisomers 8m/9m (9:1); Rf = 0.4; only 
the major regioisomer is described below. FT-IR (neat): 2957 (m), 2930 (m), 2860 (m), 2821 (m), 
1667 (vs), 1601 (m), 1468 (m), 1443, (w) 1401 (w), 1378 (w), 1336 (s), 1287 (m), 1260 (m), 1228 (m), 
1203 (m), 1148 (s), 1121 (w), 1089 (vw), 1045 (m), 1018 (m), 967 (m), 940 (m), 905 (m), 885 (m), 816 
(m), 746 cm–1 (s). 1H NMR (CDCl3, 500 MHz): δ = 7.60 (dd, J = 1.8, 0.6 Hz, 1 H), 6.73 (dd, J = 3.6, 0.5 
Hz, 1 H), 6.56 (dd, J = 3.6, 1.8 Hz, 1 H, major), 4.72 (s, 2 H), 4.20 (s, 2 H), 2.70–2.60 (m, 2 H), 1.46–
1.38 (m, 4 H), 0.94 (t, J = 7.3 Hz. 3 H). 13C NMR (CDCl3, 125 MHz): δ = 194.5 (e), 149.3 (e), 144.7 (o), 
139.6 (e), 131.8 (e), 114.4 (o), 112.3 (o), 72.1 (e), 66.0 (e), 30.6 (e), 25.1 (e), 23.1 (e), 13.9 (o). MS 
(CI): m/z (%) = 221 (100) [M + H]+. HRMS (CI): m/z [M + H]+ calcd for C13H17O3: 221.1099; found: 
221.1181. 
Nickel-Catalyzed Cycloaddition of Oct-4-yne with Oxetanone 10. Inside a glovebox, J-Young Teflon-
screw flame-dried Schlenk tube equipped with a small stirrer bar was charged with Ni(cod)2 (6 mg, 
0.022 mmol, 0.1 equiv) and taken out of the glovebox. Under N2, PPh3 (18 mg, 0.066 mmol, 0.3 
equiv) and 1,4-dioxane (1.3 mL) were added. The suspension was stirred for 5 min and then 
oxetanone 10 (39 mg, 0.22 mmol, 1 equiv) was added as solid in one portion. After stirring for 5 
more min, oct-4-yne (36 μL, 0.224 mmol, 1.1 equiv) was added and the flask was sealed and 
immersed into an oil bath pre-heated at 90 °C. After stirring for 17 h at that temperature, the 
mixture was allowed to cool and filtered through a silica plug before evaporation of all volatiles. 
Purification by flash chromatography (PE/EtOAc, 95:5) afforded 11 as a colorless oil; yield: 24 mg 
(38%) and 1:5 mixture of 11 and 12 as a colorless oil; yield: 8 mg (13%). 
2-Phenethyl-4,5-dipropyl-2H-pyran-3(6H)-one (11): FT-IR (neat): 2956 (m), 2930 (m), 1671 (vs), 1634 
(m), 1603 (w), 1496 (w), 1454 (m), 1383 (w), 1175 (m), 1126 (s), 1084 (w), 1031 (w), 745 (s), 699 cm–
1 (s). 1H NMR (CDCl3, 500 MHz): δ = 7.32–7.26 (m, 2 H), 7.25–7.14 (m, 3 H), 4.36 (d, J = 17.0 Hz, 1 H), 
4.28 (d, J = 17.0 Hz, 1 H), 3.88–3.80 (m, 1 H), 2.85–2.67 (m, 2 H), 2.33–2.11 (m, 5 H), 2.05–1.92 (m, 1 
H), 1.50 (sext, J = 7.7 Hz, 2 H), 1.36 (sext, J = 7.8 Hz, 2 H), 0.99 (t, J = 7.3 Hz, 3 H), 0.91 (t, J = 7.3 Hz, 3 
H). 13C NMR (CDCl3, 125 MHz): δ = 196.0 (e), 155.8 (e), 141.6 (e), 133.3 (e), 128.6 (o, 2 C), 128.3 (o, 
2 C), 125.8 (o), 79.0 (o), 66.9 (e), 32.6 (e), 31.7 (e), 31.3 (e), 26.3 (e), 22.5 (e), 21.4 (e), 14.3 (o), 14.2 
(o). MS (ESI): m/z (%) = 309 (100) [M + Na]+. HRMS (ESI): m/z [M + Na]+ calcd for C19H26O2Na: 
309.1831; found: 309.1837. 
6-Phenethyl-4,5-dipropyl-2H-pyran-3(6H)-one (12): 1H NMR (CDCl3, 500 MHz): δ = 7.33–7.28 (m, 2 
H), 7.24–7.18 (m, 3 H), 4.27 (d, J = 16.8 Hz, 1 H), 4.23 (dd, J = 10.1, 2.7 Hz, 1 H), 4.07 (d, J = 16.9 Hz, 1 
H), 2.92–2.83 (m, 1 H), 2.79–2.70 (m, 1 H), 2.37–2.29 (m, 1 H), 2.28–2.20 (m, 2 H), 2.11–1.88 (m, 3 
H), 1.53–1.45 (m, 1 H), 1.42–1.32 (m, 3 H), 0.95 (t, J = 7.4 Hz, 3 H), 0.92 (t, J = 7.4 Hz, 3 H). 13C NMR 
(CDCl3, 125 MHz): δ = 194.5 (e), 159.6 (e), 141.4 (e), 133.6 (e), 128.50 (o, 2 C), 128.46 (o, 2 C), 126.1 
(o), 74.6 (o), 67.8 (e), 32.7 (e), 32.5 (e), 32.3 (e), 26.4 (e), 22.6 (e), 21.8 (e), 14.4 (o), 14.2 (o). 
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